(Press-News.org) Barcelona, Spain – 10 May 2023: A small randomised trial in patients with post-COVID syndrome has found that hyperbaric oxygen therapy promotes restoration of the heart’s ability to contract properly. The research is presented at EACVI 2023, a scientific congress of the European Society of Cardiology (ESC).1
“The study suggests that hyperbaric oxygen therapy can be beneficial in patients with long COVID,” said study author Professor Marina Leitman of the Sackler School of Medicine, Tel Aviv University and Shamir Medical Centre, Be'er Ya'akov, Israel. “We used a sensitive measure of cardiac function which is not routinely performed in all centres. More studies are needed to determine which patients will benefit the most, but it may be that all long COVID patients should have an assessment of global longitudinal strain and be offered hyperbaric oxygen therapy if heart function is reduced.”
Most COVID-19 sufferers fully recover, but after the initial illness approximately 10–20% of patients develop long COVID, also called post-COVID condition or syndrome.2 Symptoms include shortness of breath, fatigue, cough, chest pain, rapid or irregular heartbeats, body aches, rashes, loss of taste or smell, nausea, vomiting, diarrhoea, headache, dizziness, insomnia, brain fog, depression and anxiety. Patients with post-COVID syndrome may also develop cardiac dysfunction and are at increased risk of a range of cardiovascular disorders.3
This randomised controlled double-blind trial evaluated the effect of hyperbaric oxygen therapy (HBOT) on the cardiac function of long COVID patients. HBOT involves inhalation of 100% pure oxygen at high pressure to increase delivery to the body’s tissues, which is particularly beneficial for tissues that are starved of oxygen due to injury or inflammation. HBOT is an established treatment for non-healing wounds, decompression sickness in divers, carbon monoxide poisoning, radiation injury and certain types of infections
The study enrolled 60 post-COVID syndrome patients with ongoing symptoms for at least three months after having mild to moderate symptomatic COVID-19 confirmed by a PCR test. Both hospitalised and non-hospitalised patients were included. Severe COVID cases were excluded. Patients were randomised to HBOT or a sham procedure in a 1:1 ratio. Each patient had five sessions per week over eight weeks, for a total of 40 sessions. The HBOT group received 100% oxygen through a mask at a pressure of 2 atmospheres for 90 minutes, with 5 minute air breaks every 20 minutes. The sham group breathed 21% oxygen by mask at 1 atmosphere for 90 minutes. All participants underwent echocardiography at baseline (before the first session) and 1 to 3 weeks after the last session.
Echocardiography was used to assess left ventricular global longitudinal strain (GLS), which is a measure of the heart’s ability to contract and relax lengthwise. It indicates how well the heart is functioning and can help detect early signs of heart disease. A healthy heart will have a GLS value of around -20% which means that the heart muscle is able to properly contract and relax in the longitudinal direction. Reduced GLS is an early marker that the heart is not able to contract and relax effectively.
At baseline, nearly half of study participants (29 out of 60; 48%) had reduced GLS. Of those, 13 (43%) and 16 (53%) were in the sham and HBOT groups, respectively. The average GLS at baseline across all participants was -17.8%. In the HBOT group, GLS significantly increased from -17.8% at baseline to -20.2% after the intervention (p=0.0001). In the sham group, GLS was -17.8% at baseline and -19.1% after the sessions, with no statistically significant difference between the two measurements.
Professor Leitman said: “It was notable that almost half of long COVID patients had impaired cardiac function at baseline according to GLS despite all participants having a normal ejection fraction, which is the standard method for measuring the heart’s ability to contract. This means that ejection fraction is not sensitive enough to identify long COVID patients with reduced heart function.”
She concluded: “The findings suggest that HBOT promotes recovery of cardiac function in patients with post-COVID syndrome. More research is needed to collect long-term results and determine the optimal number of sessions for maximum therapeutic effect.”
ENDS
Authors: ESC Press Office
Mobile: +33 (0)489 872 075
Email: press@escardio.org
Follow us on Twitter @ESCardioNews
Notes to editor
Funding: None.
Disclosures: None.
References and notes
1The abstract ‘The effect of hyperbaric oxygen therapy on myocardial function in post-COVID syndrome patients: a randomized controlled trial’ will be presented during the session ‘COVID’ which takes place on 10 May at 11:30 CEST at Moderated ePosters 1.
2World Health Organization: Coronavirus disease (COVID-19): Post COVID-19 condition.
3Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28:583–590.
About EACVI 2023 #EACVI2023
EACVI 2023 is the first patient-focused and unified multi-modality congress. It is organised by the European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology (ESC).
About the European Association of Cardiovascular Imaging (EACVI)
The European Association of Cardiovascular Imaging (EACVI) - a branch of the ESC - is the world leading network of Cardiovascular Imaging (CVI) experts, gathering four imaging modalities under one entity (Echocardiography, Cardiovascular Magnetic Resonance, Nuclear Cardiology and Cardiac Computed Tomography). Its aim is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging. The EACVI welcomes over 11,000 professionals including cardiologists, sonographers, nurses, basic scientists and allied professionals.
About the European Society of Cardiology
The European Society of Cardiology brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.
Information for journalists about registration for EACVI 2023
EACVI 2023 will be held 10 to 12 May at the Fira Gran Via, Hall 8, in Barcelona, Spain. Explore the scientific programme.
Free registration applies to accredited press.
Credentials: A valid press card or appropriate letter of assignment with proof of three recent published articles. Read the ESC media and embargo policy.
The ESC Press Office will verify the documents and confirm by email that your press accreditation is valid.
The ESC Press Office decision is final regarding all press registration requests. END
Oxygen therapy improves heart function in patients with long COVID
2023-05-10
ELSE PRESS RELEASES FROM THIS DATE:
One step closer to eliminating latency, the real challenge in combating HIV
2023-05-10
An international study led by MELIS-UPF researchers from the Infection Biology and Molecular Virology laboratories has identified and characterized Schlafen 12 (SLFN 12) as a novel HIV restriction factor. SLFN 12 shuts down viral protein production and helps virus-infected cells to escape from anti-HIV therapy and immune responses. These findings pave the way for improving therapeutic strategies that aim to cure HIV infections.
Human Immunodeficiency Virus (HIV) infections, if left untreated, lead to the gradual destruction of the immune system, AIDS, in its final stages. Worldwide, some 650,000 ...
Delivery of antioxidants to liver mitochondria
2023-05-10
A new drug delivery system delivers an antioxidant directly to mitochondria in the liver, mitigating the effects of oxidative stress.
Mitochondria are microscopic organelles found within cells, and are well-known as the “powerhouse of the cell.” They are by far the largest producer of the molecule adenosine triphosphate (ATP), which provides energy to many processes in living cells. The process by which mitochondria synthesize ATP generates a large amount of reactive oxygen species (ROS), chemical groups that are highly reactive.
In a healthy cell, the ROS are controlled by the mitochondria; however, when this balance is lost, the excess ROS damages the mitochondria ...
New breathalyzer for disease sniffs out COVID in real-time, could be used to detect cancer, lung disease
2023-05-10
With each breath, humans exhale more than 1,000 distinct molecules, producing a unique chemical fingerprint or “breathprint” rich with clues about what’s going on inside the body.
For decades, scientists have sought to harness that information, turning to dogs, rats and even bees to literally sniff out cancer, diabetes, tuberculosis and more.
Scientists from CU Boulder and the National Institute of Standards and Technology (NIST) have made an important leap forward in the quest to diagnose disease using exhaled breath, reporting that a new laser-based breathalyzer powered by artificial intelligence (AI) can detect COVID-19 in real-time with ...
Home measurement of blood oxygen levels by corona patients themselves easily applicable
2023-05-10
May 10 2023, Utrecht (The Netherlands) - When corona patients themselves measure the oxygen level in their blood at home, this is well applicable through the general practice. This was shown in a study conducted by UMC Utrecht during the pandemic. The study showed that patients could easily perform the oxygen measurement themselves at home, they felt safe doing so and the number of GP or hospital visits did not increase. The researchers believe that - by enabling care close to home - patients experience more control and that it contributes to relieving caregivers and keeping ...
Overweight boys more likely to be infertile men
2023-05-10
A new paper in the European Journal of Endocrinology, published by Oxford University Press, indicates that overweight boys tend to have lower testicular volume, putting them at risk for infertility in adulthood.
Infertility weighs on both the psychological health and the economic and social lives of people of childbearing age. Infertility affected 48 million couples in 2010. Although observers often overlook male infertility, researchers believe it is a factor contributing to couple infertility in about half of all cases. Yet ...
First structural analysis of highly reactive anionic Pt(0) complexes
2023-05-10
Anionic M0 complexes (M = group 10 metals) have attracted attention as active species for catalytic reactions; however, their molecular structures have very rarely been determined owing to their extremely high reactivity. Particularly, the structures of Pt0 complexes, which are expected to exhibit a high degree of reactivity, have not been determined, and their syntheses have been almost nonexistent.
Associate Professor Hajime Kameo, and Professor Hiroyuki Matsuzaka from the Osaka Metropolitan University Graduate School of Science and CNRS Senior Researcher Didier Bourissou (Paul Sabatier University - Toulouse III) elucidated the ...
Air pollution worsens movement disorder after stroke
2023-05-10
Air pollution has been shown to have a negative effect on the prognosis of ischemic stroke, or stroke caused by reduced blood flow to the brain, but the exact mechanism is unknown. A team of researchers recently conducted a study to determine whether or not increased inflammation of the brain, also known as neuroinflammation, is the main culprit.
The team published their findings in the February 16, 2023 issue of Particle and Fibre Toxicology.
Mice exposed intranasally to urban aerosols from Beijing, China, for one week demonstrated increased neuroinflammation ...
Most antidepressants prescribed for chronic pain lack reliable evidence of efficacy or safety, scientists warn
2023-05-10
Largest ever investigation into antidepressants used for chronic pain shows insufficient evidence to determine how effective or harmful they may be
Study reviewed commonly prescribed medications including amitriptyline, duloxetine, fluoxetine, citalopram, paroxetine, and sertraline
One third of people globally are living with long-term pain with many prescribed antidepressants to relieve symptoms
Most antidepressants used for chronic pain are being prescribed with “insufficient” evidence of their effectiveness, scientists have warned.
A major investigation into medications used to manage long-term pain found that ...
Dark clouds on the horizon
2023-05-10
Our industrialized society releases many and various pollutants into the world. Combustion in particular produces aerosol mass including black carbon. Although this only accounts for a few percent of aerosol particles, black carbon is especially problematic due to its ability to absorb heat and impede the heat reflection capabilities of surfaces such as snow. So, it’s essential to know how black carbon interacts with sunlight. Researchers have quantified the refractive index of black carbon to the most accurate degree yet which might impact climate models.
There are many factors driving climate change; some are very familiar, such ...
Scientists discover microbes in the Alps and Arctic that can digest plastic at low temperatures
2023-05-10
Finding, cultivating, and bioengineering organisms that can digest plastic not only aids in the removal of pollution, but is now also big business. Several microorganisms that can do this have already been found, but when their enzymes that make this possible are applied at an industrial scale, they typically only work at temperatures above 30°C. The heating required means that industrial applications remain costly to date, and aren’t carbon-neutral. But there is a possible solution to this problem: ...